Osteoarthritis  - Epidemiology Forecast To 2023
[Report Updated: 31-05-2017]

Published by Delve Insight: 31 May 2017 | 86113

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Osteoarthritis 
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

DelveInsight “Osteoarthritis  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Osteoarthritis  in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Osteoarthritis  prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Osteoarthritis . The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope of the Report

• The Report includes the prevalent population and how will it change over the next eight years.

• Prevalent or incident cases segmented by age and sex.

• Coverage of key Osteoarthritis  subpopulations and its prevalent or incident cases

• The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Osteoarthritis  market.

• Identifying prevalent patient populations as well as risk factors in the global Osteoarthritis  market will help to improve product design, pricing, and launch plans.

• Organize sales and marketing efforts by identifying the best opportunities for Osteoarthritis  therapeutics in each of the markets covered.

Table of Contents
for Osteoarthritis  - Epidemiology Forecast To 2023 [Report Updated: 31-05-2017]

List Of Tables
in Osteoarthritis  - Epidemiology Forecast To 2023 [Report Updated: 31-05-2017]

Table 1: Clinical subtypes of Indication

Table 2: Risk Factors

Table 3: Prevalence cases (%) Region wise

Table 4: Sources used for forecasting the data

Table 5: Osteoarthritis  Global Epidemiology, (2013-2023)

Table 6: Prevalent Cases of Osteoarthritis  (Ages =XX Years), US (2013-2023)

Table 7: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), US (2013-2023)

Table 8: Prevalent Cases By Osteoarthritis  Sub-population, US (2013-2023)

Table 9: Prevalent Cases of Osteoarthritis  (Ages =XX Years), United Kingdom (2013-2023)

Table 10: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), United Kingdom (2013-2023)

Table 11: Prevalent Cases By Osteoarthritis  Sub-population, United Kingdom (2013-2023)

Table 12: Prevalent Cases of Osteoarthritis  (Ages =XX Years), Germany (2013-2023)

Table 13: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), Germany (2013-2023)

Table 14: Prevalent Cases By Osteoarthritis  Sub-population, Germany (2013-2023)

Table 15: Prevalent Cases of Osteoarthritis  (Ages =XX Years), France (2013-2023)

Table 16: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), France (2013-2023)

Table 17: Prevalent Cases By Osteoarthritis  Sub-population, France (2013-2023)

Table 18: Prevalent Cases of Osteoarthritis  (Ages =XX Years), Italy (2013-2023)

Table 19: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), Italy (2013-2023)

Table 20: Prevalent Cases By Osteoarthritis  Sub-population, Italy (2013-2023)

Table 21: Prevalent Cases of Osteoarthritis  (Ages =XX Years), Spain (2013-2023)

Table 22: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), Spain (2013-2023)

Table 23: Prevalent Cases By Osteoarthritis  Sub-population, Spain (2013-2023)

Table 24: Prevalent Cases of Osteoarthritis  (Ages =XX Years), Japan (2013-2023)

Table 25: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), Japan (2013-2023)

Table 26: Prevalent Cases By Osteoarthritis  Sub-population, Japan (2013-2023)

List Of Figures, Charts and Diagrams
in Osteoarthritis  - Epidemiology Forecast To 2023 [Report Updated: 31-05-2017]

Figure 1: Prevalence cases (%) Region wise

Figure 2: Sources used for forecasting the data

Figure 3: Osteoarthritis  Global Epidemiology, (2013-2023)

Figure 4: Prevalent Cases of Osteoarthritis  (Ages =XX Years), US (2013-2023)

Figure 5: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), US (2013-2023)

Figure 6: Prevalent Cases By Osteoarthritis  Sub-population,US (2013-2023)

Figure 7: Prevalent Cases of Osteoarthritis  (Ages =XX Years), United Kingdom (2013-2023)

Figure 8: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), United Kingdom (2013-2023)

Figure 9: Prevalent Cases By Osteoarthritis  Sub-population,United Kingdom (2013-2023)

Figure 10: Prevalent Cases of Osteoarthritis  (Ages =XX Years), Germany (2013-2023)

Figure 11: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), Germany (2013-2023)

Figure 12: Prevalent Cases By Osteoarthritis  Sub-population,Germany (2013-2023)

Figure 13: Prevalent Cases of Osteoarthritis  (Ages =XX Years), France (2013-2023)

Figure 14: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), France (2013-2023)

Figure 15: Prevalent Cases By Osteoarthritis  Sub-population,France (2013-2023)

Figure 16: Prevalent Cases of Osteoarthritis  (Ages =XX Years), Italy (2013-2023)

Figure 17: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), Italy (2013-2023)

Figure 18: Prevalent Cases By Osteoarthritis  Sub-population,Italy (2013-2023)

Figure 19: Prevalent Cases of Osteoarthritis  (Ages =XX Years), Spain (2013-2023)

Figure 20: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), Spain (2013-2023)

Figure 21: Prevalent Cases By Osteoarthritis  Sub-population,Spain (2013-2023)

Figure 22: Prevalent Cases of Osteoarthritis  (Ages =XX Years), Japan (2013-2023)

Figure 23: Prevalent Cases of Osteoarthritis  By Sex (Males & Females), Japan (2013-2023)

Figure 24: Prevalent Cases By Osteoarthritis  Sub-population,Japan (2013-2023)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

86113 | DIEPR2017126

Number of Pages

40

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Osteoarthritis Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Osteoarthritis Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Osteoarthritis Global Clinical Trials Review, H2, 2016
Osteoarthritis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Os...
30 Sep 2016 by Global Data USD $2,500 More Info
Osteoarthritis Global Clinical Trials Review, H2, 2016
Osteoarthritis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Os...
30 Sep 2016 by Global Data USD $2,500 More Info
OpportunityAnalyzer: Osteoarthritis - Opportunity Analysis and Forecasts to 2024
OpportunityAnalyzer: Osteoarthritis - Opportunity Analysis and Forecasts to 2024SummaryOsteoarthriti...
27 Jun 2016 by Global Data USD $10,995 More Info
OpportunityAnalyzer: Osteoarthritis - Opportunity Analysis and Forecasts to 2024
OpportunityAnalyzer: Osteoarthritis - Opportunity Analysis and Forecasts to 2024SummaryOsteoarthriti...
27 Jun 2016 by Global Data USD $10,995 More Info
Osteoarthritis Pain Global Clinical Trials Review, H1, 2016
Osteoarthritis Pain Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report...
16 Mar 2016 by Global Data USD $2,500 More Info
Osteoarthritis Global Clinical Trials Review, H2, 2015
Osteoarthritis Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “Os...
30 Dec 2015 by Global Data USD $2,500 More Info
Osteoarthritis Pain Global Clinical Trials Review, H2, 2015
Osteoarthritis Pain Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report...
23 Dec 2015 by Global Data USD $2,500 More Info
Global Knee Osteoarthritis Market: Trends and Opportunities (2015-2020)
Scope of the ReportThe report titled “Global Knee Osteoarthritis Market: Trends and Opportunities (2...
01 Oct 2015 by Daedal Research USD $800 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)